View the 2024 Judges

Last year we had the pleasure of welcoming a senior panel of judges from across the advanced therapies industry. The judging panel comprises therapeutic developers, academics, investors, and leading vendors, all of whom take part in a two-stage judging process for all entries

President-Elect, ISCT

Dr. Forte has significant experience in regenerative medicine and in the cell therapy industry, most recently as Chief Execu…

CEO, OX2 Therapeutics

Jeff is a seasoned CEO with a proven track record at profitably growing emerging companies and bu…

Founder and Executive Chairman, Akron

With over 30 years of experience in the regenerative medicine industry, Dr. Zylberberg has established herself as a leader i…

Co-Founder and Executive Managing Director, Centre for Breakthrough Medicines

Audrey Greenberg is Co-founder of the Center for Breakthrough Medicines and Discovery Labs where …

CEO, Antion Biosciences

Dr Sven Kili is Chief Executive Officer at Antion Biosciences, a Multiplex Cell Engineering company developing ‘Smart-Data’ …

President and COO, Rocket Pharma

Kinnari Patel is President & Chief Operating Officer for Rocket Pharma. She oversees IT, HR, regulatory, clinical execut…

CEO, Propel Biosciences

Susan is CEO of Propel BioSciences Inc. where she leads a team who support the business development, drug development and fr…

President, Dark Horse Consulting
Founder, Emily Whitehead Foundation

Tom Whitehead is a keynote speaker, author, and journeyman lineman for Penelec, a FirstEnergy Company. He is also the proud …

Professor, University of Pennsylvania

Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, is the Founding Director of the Clinical Cell …

CEO & Founder, Siren Biotechnology
Chief Clinical Officer, Cell & Gene Therapy Catapult
Director, Powell Gene Therapy Center, University of Florida

 

 

Professor, University of Pennsylvania
Interim Executive Director, Emily Whitehead Foundation

 

 

Chief Scientific Officer, T-knife Therapeutics

 

 

VP, Research Therapy Acceleration Program, The Leukemia & Lymphoma Society